KOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors. KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.
Investigated for use/treatment in solid tumors.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.